Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAS-HIV: Valsartan for Mitochondrial Decline in HIV
NCT02606279Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jul 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of valsartan in Sarcopenia and Mitochondriopathy, sponsored by Wake Forest University Health Sciences. Primary endpoint: Change From Baseline in 400m Walk at 9 months. Started Jul 2014; status: terminated.
02
Drugs
valsartan
03
Conditions
SarcopeniaMitochondriopathy
Beyond the preview
Go deeper on NCT02606279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02606279.